Vestas Wind Systems Shares Decline After Margin Guidance Revision Top Economists Forecast Inflation to Reach 6 in Q2 Amid Persistent Price Pressures California Apparel and Retail Sector Gains Legal Support Amidst Surge in Sustainability Mandates Berkshire Hathaway Revamps Portfolio New Stakes in Delta Air Lines Alphabet Increase Quarterly Earnings in Jeopardy Traders Speculate on Timeline for Potential Shift Toward Less Frequent Reporting Q4 Results Roundup Graphite India Posts Loss Alkem Lab and Anup Engineering Profit Drops Multiple Companies Announce Earnings GCTS Q1 2026 Earnings EPS Misses Estimates Slightly as PreRevenue Semiconductor Firm Reports Narrow Loss Upstream Bio UPB Q1 2026 Earnings NarrowerthanExpected Loss with No Revenue Yet MCK Q1 2026 Earnings EPS Beats Estimates by a Narrow Margin SLDP Q1 2026 Earnings Solid Power Beats EPS Estimates by a Wide Margin PreRevenue Status Maintained Home Bancorp Inc Q1 2026 Earnings Modest EPS Beat Amid Quiet Revenue Disclosure Dicks Sporting Goods Inc DKS Q1 2026 Earnings EPS Surges Past Estimates Stock Rises RENN Fund Inc RCG Edges Higher Testing Key Resistance Levels Gilead Sciences GILD Edges Higher Modestly as Shares Hold Above Key Support ProCap Acquisition Corp Warrant PCAPW Holds Steady at 035 Amid Low Volume SmithMidland Corporation SMID Gains Momentum Testing Key Resistance Praetorian Acquisition Corp Units PTORU Holding Steady at 100 Analysis of Key Levels and Potential Catalysts Jim Cramers Latest Claim on CrowdStrike Sparks Market Speculation MYSZ Q4 2025 Earnings EPS Misses Estimates No Revenue Reported ZoomInfo GTM Slides 714 to 325 Key Support Test Looms Regional Management RM Stock Jumps 284 Approaching 3693 20260518 Altria Group MO Delivers Q1 2026 Beat EPS 132 vs 128 Expected Should You Sell Fate Therapeutics FATE After 142 Drop 20260518 Battalion Oil BATL Q2 2023 Earnings Why the Beat Matters The Fed Will Have a New Chair It Also Has an Inflation Problem Global Markets Steady as Oil Retreats Following Trumps Remarks on Iran Amgen Inc Faces Mixed Analyst Sentiment Amid Biotech Sector Headwinds